Barclays’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Barclays’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,128,949	Closed	-$38.4M	–	7529
2014 Q4	$38.4M	Sell	1,128,949 -1,124,993	-50%	-$36.7M	0.04%	449
2014 Q3	$65.4M	Buy	2,253,942 +1,906,294	+548%	+$40.4M	0.06%	253
2014 Q2	$6.95M	Buy	347,648 +321,738	+1,242%	+$7.38M	0.01%	1445
2014 Q1	$699K	Sell	25,910 -196,271	-88%	-$5.21M	﹤0.01%	3617
2013 Q4	$4.44M	Buy	222,181 +118,226	+114%	+$2.23M	﹤0.01%	1930
2013 Q3	$1.87M	Sell	103,955 -152,706	-59%	-$2.76M	﹤0.01%	2660
2013 Q2	$4.27M	Buy	+256,661	New	+$4.1M	0.01%	1753

Other funds holding AUXL

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Barclays's AUXL Position: Q1 2015 in Review

Barclays sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 1,128,949 shares — an estimated $38.4M sold.

Barclays first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $65.4M in Q3 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

Barclays reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Barclays sold 1,128,949 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $38.4M.
Barclays first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
Barclays's AUXILIUM PHARAMCEUTICALS INC position peaked at $65.4M in Q3 2014.
1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Barclays's 13F filing for Q1 2015, filed 14 May 2015.